Stephens Upgrades Zions Bancorporation to Buy, Sets $79 Target
Stephens has upgraded Zions Bancorporation to a buy rating with a new price target of $79.
Key Points
- Stephens analyst Matt Olney raised Zions Bancorporation's rating to buy, setting a $79 price target on June 15, 2026.
- Shares of NasdaqGS:ZION traded at $67.25 with a market cap of $9.75 billion and a P/E ratio of 10.29.
- Insiders and analysts show mixed activity, with recent insider sales and a variety of analyst ratings.
Stephens analyst Matt Olney has upgraded his rating on Zions Bancorporation, National Association (NasdaqGS:ZION) to 'buy' and set a new price target of $79. This update was announced on June 15, 2026, as shares traded around $67.25.
What Changed in Stephens's Zions Bancorporation Position
Stephens's decision to raise the rating to 'buy' signals confidence in Zions Bancorporation's prospects. The new price target of $79 suggests an upside potential from the current trading price.
Other Institutional Activity in Zions Bancorporation
Several institutional investors have recently adjusted their holdings in Zions Bancorporation. BlackRock, Inc. increased its position by 279,696 shares, bringing its total to 14,020,532 shares worth about $807.9 million. Vanguard Portfolio Management LLC also made a significant addition, acquiring 10,855,578 shares, now valued at approximately $625.5 million. Dimensional Fund Advisors LP added 56,438 shares, ending with 7,477,126 shares valued at $430.8 million. Meanwhile, State Street Corp reduced its stake by 200,817 shares to 5,883,024 shares, worth around $339.0 million.
Zions Bancorporation Stock Snapshot
Shares of Zions Bancorporation are trading at $67.25, with a market capitalization of approximately $9.75 billion. The company's P/E ratio stands at 10.29, and its forward P/E is 9.89. With a beta of 0.811, the stock has shown stability compared to the market. Its 52-week range is $46.19 to $67.99, with a 50-day moving average of $62.25 and a 200-day moving average of $58.15.
Recent Earnings
Zions Bancorporation reported revenue of $3.39 billion, reflecting a growth of 10.2%. The company achieved a net margin of 28.4% and a return on equity of 14.1%. Earnings per share (EPS) came in at $6.44. The next earnings release is scheduled for July 20, 2026.
Dividend
The company offers an annual dividend rate of $1.80, yielding 2.72%, with a dividend payout ratio of 27.6%.
Insider Buying and Selling at Zions Bancorporation, National Association
Recent insider activity at Zions Bancorporation includes Ryan Daniel Joseph buying 1,921 shares at an average price of $62.02 on June 2, 2026. In contrast, Nathan Callister, Executive Vice President, sold 922 shares on the same day. Jennifer Anne Smith, another Executive Vice President, sold 4,209 shares at $62.50 on May 8, 2026.
Analysts Set New Price Targets
On June 15, 2026, Stephens & Co. reinstated its 'buy' rating with a $79 target. Other analysts have mixed views: Citigroup maintained a 'hold' rating with a $66 target, while Barclays rated it 'sell' at $72. DA Davidson maintained a 'buy' with a $78 target.
About Zions Bancorporation
Zions Bancorporation, National Association, is a regional bank headquartered in Salt Lake City, Utah. It provides a wide range of banking services across several Western U.S. states, including commercial and small business banking, retail banking, and wealth management. The bank operates through various segments such as Zions Bank and California Bank & Trust, among others. Led by CEO Harris Henry Simmons, the company employs around 9,090 people.
Bottom Line
Stephens's upgrade to a 'buy' rating with a $79 target reflects a positive outlook for Zions Bancorporation. While the stock shows potential for growth, investors should remember that 13F filings and analyst ratings are backward-looking and may not represent current market conditions. Always consider multiple data points when evaluating investment decisions.
See Also
This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.
